Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Axios on MSN
Longevity medicine's do-or-die moment
The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...
People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary ...
Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype ...
Researchers developed an OSK therapy that can partially reset epigenetic aging in optic neurons. Preclinical data ...
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...
Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and disease progression. In gynecological malignancies-including ovarian, cervical, and ...
The Hearty Soul on MSN
The world's first reverse aging drug was just injected into a human
The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results